| 1 |
30192871 | Impaired hepatic amyloid-beta degradation in Alzheimer's disease. | 2018 |
1 |
| 2 |
26444783 | Age and its association with low insulin and high amyloid-β peptides in blood. | 2016 |
1 |
| 3 |
21418385 | Epitope-dependent effects of Beta-amyloid antibodies on Beta-amyloid clearance in an in vitro model of the blood-brain barrier. | 2011 Jul |
2 |
| 4 |
20002523 | Inhibition of Abeta aggregation and neurotoxicity by the 39-kDa receptor-associated protein. | 2010 Mar |
2 |
| 5 |
12659848 | Formation of a membrane-active form of amyloid beta-protein in raft-like model membranes. | 2003 Apr 4 |
1 |
| 6 |
12867419 | Kinetics of amyloid beta-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays. | 2003 Sep 26 |
2 |
| 7 |
12032144 | Accelerated phagocytosis of amyloid-beta by mouse and human microglia overexpressing the macrophage colony-stimulating factor receptor. | 2002 Aug 16 |
1 |
| 8 |
11019856 | Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system. | 2000 Sep |
1 |
| 9 |
11086258 | Protocol for quantitative and qualitative analyses of the in vitro aggregation of synthetic beta-amyloid. A method applicable to the identification of substances that may have therapeutic efficacy for Alzheimer's disease. | 2000 Nov |
1 |
| 10 |
9261105 | Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations. | 1997 Aug 22 |
3 |
| 11 |
1405489 | Beta protein precursor expression in human platelets and a megakaryocyte cell line. Possible implications for the origin of cerebral amyloidosis in Alzheimer's disease. | 1992 Sep |
1 |